Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

DarioHealth Corp

Healthcare US DRIO

7.65USD
0.00(0%)

Last update at 2026-06-03T20:00:00Z

Day Range

7.417.90
LowHigh

52 Week Range

5.9317.74
LowHigh

Fundamentals

  • Previous Close 7.65
  • Market Cap53.11M
  • Volume6788
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-33.51700M
  • Revenue TTM22.36M
  • Revenue Per Share TTM5.61
  • Gross Profit TTM 14.34M
  • Diluted EPS TTM-10.12

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -41.60900M -44.59900M -59.36300M -62.18900M -76.72900M
Minority interest - - - - -
Net income -41.71400M -42.74700M -59.42700M -62.19300M -76.76100M
Selling general administrative 15.19M 20.48M 18.01M 16.49M 23.53M
Selling and marketing expenses 20.34M 26.35M 23.79M 30.32M 39.71M
Gross profit 12.66M 13.27M 5.98M 9.65M 3.96M
Reconciled depreciation 3.14M 7.43M 4.92M 4.72M 3.32M
Ebit -36.65500M -57.74400M -59.36300M -56.81000M -76.49400M
Ebitda -33.09600M -50.31700M -54.37800M -52.39400M -72.98200M
Depreciation and amortization 3.56M 7.43M 4.99M 4.42M 3.51M
Non operating income net other - - - -5.37900M -0.23500M
Operating income -36.65500M -57.74400M -56.18900M -56.81000M -76.49400M
Other operating expenses 59.01M 84.78M 76.41M 84.47M 97.01M
Interest expense 3.36M 0.10M 0.65M 1.88M 0.43M
Tax provision 0.10M -1.85200M 0.00300M 0.00400M 0.03M
Interest income 0.94M 1.12M 1.68M 0.51M 0.04M
Net interest income -6.25800M 1.02M -0.82000M -2.17700M -0.04000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.10M -1.85200M 0.06M 0.00400M 0.03M
Total revenue 22.36M 27.04M 20.35M 27.66M 20.51M
Total operating expenses 49.32M 71.01M 62.17M 66.47M 80.46M
Cost of revenue 9.69M 13.77M 14.37M 18.00M 16.55M
Total other income expense net -4.95400M 13.14M -3.17400M -5.37900M -0.23500M
Discontinued operations - - - - -
Net income from continuing ops -41.71400M -42.74700M -57.75800M -62.19300M -76.76100M
Net income applicable to common shares - - - -62.19300M -78.76600M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 110.08M 118.88M 96.39M 119.19M 100.77M
Intangible assets 15.93M 18.76M 5.40M 9.92M 12.46M
Earning assets - - - - -
Other current assets 1.58M 1.96M 1.54M 1.79M 1.78M
Total liab 42.15M 46.87M 38.24M 39.19M 15.22M
Total stockholder equity 67.92M 72.02M 58.14M 80.00M 85.55M
Deferred long term liab - - - 0.91M -
Other current liab 5.25M 6.05M 6.30M 6.59M 7.81M
Common stock 0.00400M 0.00400M 0.00300M 0.00300M 0.00200M
Capital stock 0.00400M 0.00400M 0.00300M 0.00300M 0.00200M
Retained earnings -452.07800M -390.34300M -349.36100M -285.85000M -222.01400M
Other liab - - - 0.91M 0.82M
Good will 57.43M 57.43M 41.64M 41.64M 41.64M
Other assets - -0.25900M - 0.12M 0.08M
Cash 26.25M 27.76M 37.09M 49.36M 35.81M
Cash and equivalents - - - - -
Total current liabilities 9.32M 16.64M 12.49M 19.35M 14.38M
Current deferred revenue 0.71M 1.58M 1.00M 1.32M 1.20M
Net debt 5.50M 2.43M -7.54800M -21.30900M -35.52100M
Short term debt 0.43M 5.96M 4.07M 9.12M 0.27M
Short long term debt - 5.45M 3.95M 8.82M -
Short long term debt total 31.75M 30.19M 29.54M 28.05M 0.29M
Other stockholder equity 520.00M 462.36M 407.50M 365.85M 307.56M
Property plant equipment - - - 0.79M 0.70M
Total current assets 34.81M 40.53M 47.09M 65.52M 45.60M
Long term investments - - - - -
Net tangible assets - - - 28.44M 31.45M
Short term investments 4.21M 0.70M - - -
Net receivables 2.67M 5.35M 3.40M 7.14M 1.79M
Long term debt 30.75M 23.47M 24.59M 18.11M -
Inventory 4.32M 4.75M 5.06M 7.96M 6.23M
Accounts payable 2.93M 3.04M 1.13M 2.32M 5.11M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - 0.00300M 0.00200M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -285.85000M -222.01400M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.83M 0.39M -5.02300M 0.12M 0.08M
Deferred long term asset charges - - - - -
Non current assets total 75.27M 78.36M 49.30M 53.67M 55.17M
Capital lease obligations 1.00M 1.27M 1.00M 1.12M 0.29M
Long term debt total - - - 18.11M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -4.20000M -8.93400M -0.52300M -0.57300M -0.40000M
Change to liabilities - - - -4.59800M -0.28800M
Total cashflows from investing activities -4.34200M -8.93400M -0.54700M -0.57300M -8.13400M
Net borrowings 0.18M 0.00000M 1.77M 23.79M 23.79M
Total cash from financing activities 24.31M 38.53M 18.25M 61.94M 65.77M
Change to operating activities - - - -1.90000M -1.41800M
Net income -41.71400M -42.74700M -59.42700M -62.19300M -76.76100M
Change in cash -5.96100M -9.03300M -12.67300M 13.52M 7.22M
Begin period cash flow 27.76M 36.80M 49.47M 35.95M 28.73M
End period cash flow 21.80M 27.76M 36.80M 49.47M 35.95M
Total cash from operating activities -25.94100M -38.56200M -30.37900M -47.84500M -50.40900M
Issuance of capital stock 24.13M 38.53M 16.75M 38.29M 64.88M
Depreciation 2.83M 7.43M 4.99M 4.72M 3.32M
Other cashflows from investing activities - - - -0.13100M -7.47300M
Dividends paid - - - - -
Change to inventory 0.44M 0.31M 2.89M -1.72800M -2.23000M
Change to account receivables 2.64M 1.60M 2.83M -5.10600M -0.35100M
Sale purchase of stock - - 0.00000M -0.13400M 65.77M
Other cashflows from financing activities - 38.53M 14.87M 23.79M 0.89M
Change to netincome - - - 16.98M 24.97M
Capital expenditures 0.14M 0.14M 0.58M 0.57M 0.26M
Change receivables - - - -5.10600M -0.35100M
Cash flows other operating - - - 0.04M 0.93M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - 13.52M 7.22M
Change in working capital 2.21M -2.47000M 4.07M -10.89900M -2.57300M
Stock based compensation 9.37M 15.80M 19.70M 16.98M 24.97M
Other non cash items 1.37M -16.56800M 0.29M 3.56M 0.64M
Free cash flow -26.08300M -38.70000M -30.96300M -48.41800M -50.67000M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DRIO
DarioHealth Corp		 - -% 7.65 - 8.25 2.38 0.80 2.69 -0.5861
VEEV
Veeva Systems Inc Class A		 -4.22 2.31% 178.72 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.064 1.34% 4.71 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock		 1.54 2.60% 60.88 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

View All

Profile

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Corp

322 W. 57th Street, New York, NY, United States, 10019

Key Executives

Name Title Year Born
Mr. Erez Raphael CEO & Director 1973
Mr. Richard A. Anderson Pres 1969
Mr. Zvi Ben David CFO, Treasurer & Sec. 1961
Mr. Dror Bacher Chief Operating Officer 1975
Dov Oppenheim Co-Founder & Production Chief NA
Josh Fischer Sr. VP of Operations & Compliance NA
Claudia Levi Content & Communications Mang. NA
Mary Mooney VP of Marketing NA
Limor Drezner VP HR & Chief of Staff NA
Mr. Olivier R. Jarry Sr. VP of Strategy & Bus. Devel. 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.